HCID 54062527, compound → HCID 22128508, compound
Reaction equation
[O:1]1[C:6]2[CH:7]=[CH:8][C:9]([CH2:11][O:12][CH:13]3[CH:18]([C:19]4[CH:24]=[CH:23][C:22]([F:25])=[CH:21][CH:20]=4)[CH2:17][CH2:16][N:15](C(OC(C)(C)C)=O)[CH2:14]3)=[CH:10][C:5]=2[O:4][CH2:3][CH2:2]1>C(Cl)Cl.[Br-].[Zn+2].[Br-]>[O:1]1[C:6]2[CH:7]=[CH:8][C:9]([CH2:11][O:12][CH:13]3[CH:18]([C:19]4[CH:20]=[CH:21][C:22]([F:25])=[CH:23][CH:24]=4)[CH2:17][CH2:16][NH:15][CH2:14]3)=[CH:10][C:5]=2[O:4][CH2:3][CH2:2]1Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
A solution of 280 mg (0.63 mmol) of tert-butyl (3RS,4RS)-3-(2,3-dihydro-benzo[1,4]dioxin-6-ylmethoxy)-4-(4-fluorophenyl)-piperidine-1-carboxylate in 5 ml of dry methylene chloride was treated with 808 mg (1.89 mmol) of anhydrous zinc bromide and the mixture was stirred at room temperature for 5 hours. Subsequently, the solvent was distilled off under reduced pressure, the residue was taken up in 10 ml of methanol, treated with 2 ml of 2N sodium hydroxide solution and the solid was separated. The filtrate was evaporated under reduced pressure and the residue was partitioned between methylene chloride and water. The organic phase was separated and evaporated under reduced pressure. There were obtained 220 mg (98% of theory) of (3RS,4RS)-3-(2,3-dihydrobenzo[1,4]dioxin-6-yl-methoxy)-4-(4-fluorophenyl)-piperidine as a yellowish solid; MS: 344 (M+H)+.
Workup
- distillationSubsequently, the solvent was distilled off under reduced pressure
- additiontreated with 2 ml of 2N sodium hydroxide solution
- customthe solid was separated
- customThe filtrate was evaporated under reduced pressure
- customthe residue was partitioned between methylene chloride and water
- customThe organic phase was separated
- customevaporated under reduced pressure
Sources & evidence
- ORD record
- ord-a041aa7b316e4b2a8c6499e5878704f9
- Source dataset
- uspto-grants-2000_11
- Patent number
- US06150526
Reaction notes
Loading…